These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26764301)

  • 1. [Scans without Evidence of Dopamine Deficit (SWEDDs)].
    Mukai Y; Murata M
    Brain Nerve; 2016 Jan; 68(1):73-81. PubMed ID: 26764301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study.
    Schwingenschuh P; Ruge D; Edwards MJ; Terranova C; Katschnig P; Carrillo F; Silveira-Moriyama L; Schneider SA; Kägi G; Palomar FJ; Talelli P; Dickson J; Lees AJ; Quinn N; Mir P; Rothwell JC; Bhatia KP
    Mov Disord; 2010 Apr; 25(5):560-9. PubMed ID: 20131394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of Monosymptomatic Resting Tremor in a Prospective Study: Clinical Features, Electrophysiological Test, and Dopamine Transporter Positron Emission Tomography.
    Zheng HG; Zhang R; Li X; Li FF; Wang YC; Wang XM; Lu LL; Feng T
    Chin Med J (Engl); 2015 Jul; 128(13):1765-71. PubMed ID: 26112718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).
    Silveira-Moriyama L; Schwingenschuh P; O'Donnell A; Schneider SA; Mir P; Carrillo F; Terranova C; Petrie A; Grosset DG; Quinn NP; Bhatia KP; Lees AJ
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):744-8. PubMed ID: 19276101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait in SWEDDs patients: comparison with Parkinson's disease patients and healthy controls.
    Mian OS; Schneider SA; Schwingenschuh P; Bhatia KP; Day BL
    Mov Disord; 2011 Jun; 26(7):1266-73. PubMed ID: 21442658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs).
    Utiumi MA; Felício AC; Borges CR; Braatz VL; Rezende SA; Munhoz RP; Bressan RA; Ferraz HB; Teive HA
    Arq Neuropsiquiatr; 2012 Sep; 70(9):667-73. PubMed ID: 22990721
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W; Kohara S; Hashimoto J
    Clin Neurol Neurosurg; 2017 Sep; 160():73-77. PubMed ID: 28689103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study.
    Batla A; Erro R; Stamelou M; Schneider SA; Schwingenschuh P; Ganos C; Bhatia KP
    Mov Disord; 2014 Dec; 29(14):1820-5. PubMed ID: 25350529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
    Ba F; Martin WR
    Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs).
    Schneider SA; Edwards MJ; Mir P; Cordivari C; Hooker J; Dickson J; Quinn N; Bhatia KP
    Mov Disord; 2007 Nov; 22(15):2210-5. PubMed ID: 17712858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
    Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
    Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Questionnaire survey of Scans Without Evidence of Dopaminergic Deficit (SWEDD) in Japan].
    Mukai Y; Takahashi Y; Murata M
    Rinsho Shinkeigaku; 2018 Sep; 58(9):549-555. PubMed ID: 30175806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-Hour Ambulatory Blood Pressure Monitoring in SWEDDs Patients With Parkinsonism.
    Kang SJ; Ahn JY; Kim JS; Cho JW; Kim JY; Choi YY; Kim HT
    Can J Neurol Sci; 2016 May; 43(3):390-7. PubMed ID: 26853109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of DAT-SPECT in the diagnostic work up of parkinsonism.
    Scherfler C; Schwarz J; Antonini A; Grosset D; Valldeoriola F; Marek K; Oertel W; Tolosa E; Lees AJ; Poewe W
    Mov Disord; 2007 Jul; 22(9):1229-38. PubMed ID: 17486648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism.
    Taylor S; Gafton J; Shah B; Pagano G; Chaudhuri KR; Brooks DJ; Pavese N
    Mov Disord; 2016 Mar; 31(3):344-51. PubMed ID: 26863920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging dopamine transporters in Parkinson's disease.
    Brooks DJ
    Biomark Med; 2010 Oct; 4(5):651-60. PubMed ID: 20945978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nuclear neuroimaging of dopamine transporter in Parkinsonism--role in routine clinical practice].
    Cohenpour M; Golan H
    Harefuah; 2007 Sep; 146(9):698-702, 733. PubMed ID: 17969308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs.
    Jang W; Kim JS; Cho JW; Kim YH; Kim JY; Choi YY; Kim HT
    Neurol Sci; 2013 Aug; 34(8):1375-82. PubMed ID: 23179185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of dopamine transporters.
    Brooks DJ
    Ageing Res Rev; 2016 Sep; 30():114-21. PubMed ID: 26802555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD).
    Suwijn SR; Samim H; Eggers C; Espay AJ; Fox S; Lang AE; Samuel M; Silverdale M; Verschuur CVM; Dijk JM; Verberne HJ; Booij J; de Bie RMA
    J Parkinsons Dis; 2020; 10(4):1561-1569. PubMed ID: 32597819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.